About Jennifer Fox
Form D filings for Zenas BioPharma in 2024 list Jennifer Fox as executive officer.
Jennifer Fox first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jennifer Fox in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jennifer Fox works with at each company, as listed on that company's latest Form D.
Zenas BioPharma, Inc. · Form D, May 14, 2024
PE
Patrick Enright
Director
TK
Tomas Kiselak
Director
PA
Patricia Allen
Director
JF
Joseph Farmer
PRESIDENT and CHIEF OPERATING OFFICER
LJ
Leon Moulder, Jr.
Executive officer and director
JN
Jake Nunn
Director
TX
Tim Xiao
Director
JB
James Boylan
Director
TF
Tanya Fischer
Executive officer
JO
John Orloff
Director
HL
Hongbo Lu
Director